News Daily News SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide Michael O'Riordan December 18, 2025
News Daily News Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC Yael L. Maxwell August 18, 2025
News Daily News Majority of US Adults Have High Long-term Risk of CVD: NHANES Michael O'Riordan June 13, 2025
News Daily News Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data Michael O'Riordan November 07, 2024
News Daily News Top General Cardiology and CVD Prevention News of 2023 Yael L. Maxwell January 03, 2024
News Daily News Mortality Risk Varies Among Patients With Very High LDL Levels Michael O'Riordan November 17, 2023
News Daily News Half of American Indian and Alaska Native Seniors Have CVD: Medicare Analysis L.A. McKeown September 25, 2023
News Daily News New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF L.A. McKeown April 19, 2023
News Daily News Ezetimibe Plus Moderate-Dose Statins May Aid Compliance in the Elderly Yael L. Maxwell April 03, 2023
News Daily News ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly L.A. McKeown December 22, 2022
News Daily News Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis Michael O'Riordan February 18, 2022
News Daily News Risk Factors Still Matter for Patients With Zero CAC Score: MESA Yael L. Maxwell December 14, 2021
News Daily News Experts Fear Coronary CT Advice for Patients Misses the Mark Michael O'Riordan March 19, 2021
News Daily News Rosuvastatin-Canagliflozin Combo May Be Toxic, Case Suggests Todd Neale August 03, 2020
News Daily News Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease Michael O'Riordan March 13, 2020
News Daily News New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients Michael O'Riordan October 22, 2019
News Daily News Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients Michael O'Riordan August 22, 2019
News Daily News Statin Benefits: Yes for CVD but No for Everything Else, Says New Review Michael O'Riordan October 08, 2018